Supplementary Tables 1 - 3 from Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression

Autor: C. Patrick Reynolds, Timothy J. Triche, Daryl C. Drummond, Jonathan B. Fitzgerald, Winford Ko, Ashly Hindle, Riza E. Cruz, Ruben I. Calderon, Michael M. Song, Connor P. Hall, Nancy Paz, Joo-Sang Lee, Monish R. Makena, Jing Wang, Min H. Kang
Rok vydání: 2023
Popis: Supplementary Table 1. Human EFT, RMS, and NB cell lines used for current study. Supplementary Table 2. Median Survival of xenograft mice bearing human pediatric cancer treated with irinotecan or nal-IRI. Supplementary Table 3. Pharmacokinetic variables for irinotecan and nal-IRI following intravenous injections in mice.
Databáze: OpenAIRE